10.1016/j.phrs.2017.01.032 16 FengY.WangJ.LiM.TianY.ZhaoA.LiL.et al (2022)
Topical application: skin surface anti-aging, wrinkle reduction, facial skin rejuvenation, localized wound care, and hair growth support where scalp delivery is the target Subcutaneous injection: post-surgical wound recovery, systemic wound healing support, GI mucosal healing protocols, and combination use with BPC-157 and TB-500 Topical delivery challenges: GHK-Cu does not penetrate the skin barrier easily in standard formulations
Starting doses begin at 0.25 mg and may reach 14 mg daily, compared to injectable doses that start at 0.25 mg weekly and cap at 2.4 mg weekly
Shaking creates foam, introduces air throughout the solution, and generates mechanical stress that can denature the peptide
Blood cancers including chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia cause persistently high counts often exceeding 10,000-20,000 cells per microliter, unlike temporary infection-related spikes
